Cargando…

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children

BACKGROUND: Several association studies have shown that -844 G/A and HindIII C/G PAI-1 polymorphisms are related with increase of PAI-1 levels, obesity, insulin resistance, glucose intolerance, hypertension and dyslipidemia, which are components of metabolic syndrome. The aim of this study was to an...

Descripción completa

Detalles Bibliográficos
Autores principales:	De la Cruz-Mosso, Ulises, Muñoz-Valle, José F, Salgado-Goytia, Lorenzo, García-Carreón, Adrián, Illades-Aguiar, Berenice, Castañeda-Saucedo, Eduardo, Parra-Rojas, Isela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359181/ https://www.ncbi.nlm.nih.gov/pubmed/22459021 http://dx.doi.org/10.1186/1471-2431-12-41

Ejemplares similares

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
por: Valdés-Alvarado, Emmanuel, et al.
Publicado: (2019)

Association of the Hindiii and S447X Polymorphisms in Lpl Gene with Hypertension and Type 2 Diabetes in Mexican Families
por: Muñoz-Barrios, Salvador, et al.
Publicado: (2012)

The -844 G>A PAI-1 Polymorphism Is Associated with Acute Coronary Syndrome in Mexican Population
por: García-González, Ilian Janet, et al.
Publicado: (2015)

Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
por: Palacio Rojas, Marcos, et al.
Publicado: (2018)

Analysis of the HindIII-catalyzed reaction by time-resolved crystallography
por: Kawamura, Takashi, et al.
Publicado: (2015)

HindIII-based restriction fragment length polymorphism in hemophilic and nonhemophilic patients
por: Dubey, Alok Kumar, et al.
Publicado: (2010)

Heterogeneity in sensitivity to cleavage by the restriction endonucleases ECORI and HindIII of circular kinetoplast DNA molecules of Crithidia acanthocephali
Publicado: (1978)

Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer’s Disease
por: Sayad, Azadeh, et al.
Publicado: (2012)

The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City
por: Ahmadi, Zeinab, et al.
Publicado: (2015)

Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
por: Kumar, Sunil, et al.
Publicado: (2021)

Association Study between BGLAP Gene HindIII Polymorphism and Type 2 Diabetes Mellitus Development in Ukrainian Population
por: Chumachenko, Yaroslav D., et al.
Publicado: (2019)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
por: Radilla-Vázquez, Romina Belén, et al.
Publicado: (2016)

The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis
por: Cao, Limei, et al.
Publicado: (2018)

Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population
por: Bogari, Neda M., et al.
Publicado: (2020)

Application of Indirect Linkage Analysis for Carrier Detection of Hemophilia A in Kurdistan Region of Iraq: Usefulness of Intron 18 BclI T>A, Intron 19 HindIII C>T, and IVS7 nt27 G>A Markers
por: Abdulqader, Aveen M. Raouf, et al.
Publicado: (2019)

Macrophage Migration Inhibitory Factor Promoter Polymorphisms (−794 CATT(5–8) and −173 G>C): Relationship with mRNA Expression and Soluble MIF Levels in Young Obese Subjects
por: Matia-García, Inés, et al.
Publicado: (2015)

A possible association between the -2518 A>G MCP-1 polymorphism and insulin resistance in school children
por: Matia-García, Inés, et al.
Publicado: (2018)

Interleukin-6 Gene Promoter Polymorphisms and Cardiovascular Risk Factors. A family study
por: Guzmán-Guzmán, Iris Paola, et al.
Publicado: (2010)

FasL −844T/C and Fas −1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances
por: Zhao, Hongguang, et al.
Publicado: (2015)

Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects
por: Ramos-Arellano, Luz E, et al.
Publicado: (2014)

Combined Administration of Streptozotocin and Sucrose Accelerates the Appearance of Type 2 Diabetes Symptoms in Rats
por: Barragán-Bonilla, Martha Isela, et al.
Publicado: (2019)

Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus
por: Hernández-Bello, Jorge, et al.
Publicado: (2016)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Obesity, dyslipidemia, and high blood pressure are associated with cardiovascular risk, determined using high-sensitivity C-reactive protein concentration, in young adults
por: Ramos-Arellano, Luz Elena, et al.
Publicado: (2020)

Pauli Manuscript Collection: A. Pais and G. E. Uhlenbeck
por: Pauli, Wolfgang
Publicado: (2002)

Changes in the Expression of Insulin Pathway, Neutrophil Elastase and Alpha 1 Antitrypsin Genes from Leukocytes of Young Individuals with Insulin Resistance
por: Cruz-Pineda, Walter David, et al.
Publicado: (2022)

The regulatory role of insulin in energy metabolism and leukocyte functions
por: Cruz‐Pineda, Walter David, et al.
Publicado: (2021)

Adenovirus-36 Seropositivity and Its Relation with Obesity and Metabolic Profile in Children
por: Parra-Rojas, Isela, et al.
Publicado: (2013)

CD36 haplotypes are associated with lipid profile in normal-weight subjects
por: Ramos-Arellano, Luz E, et al.
Publicado: (2013)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013)

The association between the 844ins68 polymorphism in the CBS gene and breast cancer
por: Gallegos-Arreola, Martha Patricia, et al.
Publicado: (2014)

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015)

PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients
por: Szegedi, István, et al.
Publicado: (2019)

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions
por: Zubillaga-Guerrero, MI, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uskjc9je6rbg4i2rc59on024ko